Emma Sceats
Sales & Marketing bei ABCAM PLC
Profil
Emma Sceats is currently the Chief Executive Officer at Calico Biolabs, Inc. and the SVP-Sales, Service & Business Development at Abcam Plc.
Previously, she served as the Chief Executive Officer at Isogenica Ltd.
and as the Commercial Manager at CN Bio Innovations Ltd.
Dr. Sceats holds a doctorate degree from the University of Oxford, a graduate degree from the Massachusetts Institute of Technology, and an undergraduate degree from the University of Bristol (conferred in 2002).
Aktive Positionen von Emma Sceats
| Unternehmen | Position | Beginn |
|---|---|---|
| ABCAM PLC | Sales & Marketing | - |
Calico Biolabs, Inc.
 Calico Biolabs, Inc. Medical/Nursing ServicesHealth Services Part of Abcam Plc, Calico Biolabs, Inc. is a private company that develops custom rabbit monoclonal antibodies for research and diagnostic use. The company is based in Pleasanton, CA. The company was founded in 2011 by Robert Pytela. The CEO is Emma Sceats. Calico Biolabs was acquired by Abcam Plc on January 28, 2019. | Chief Executive Officer | - |
Ehemalige bekannte Positionen von Emma Sceats
| Unternehmen | Position | Ende |
|---|---|---|
Isogenica Ltd.
 Isogenica Ltd. Miscellaneous Commercial ServicesCommercial Services Isogenica Ltd. provides research and development services in the fields of new peptide, antibody and other polypeptide drug candidates. It offers llamdA System, Xab System and 4D Fab System. The company was founded by Kevin Fitzgerald in 2000 and is headquartered in Little Chesterford, the United Kingdom. | Chief Executive Officer | - |
CN Bio Innovations Ltd.
 CN Bio Innovations Ltd. BiotechnologyHealth Technology CN Bio Innovations Ltd. develops and supplies bioengineered solutions. Its products include liver chip system, tissue flex system, contract research services, drug safety profiling, drug metabolism, bespoke tissue models & applications development and technical support. The company was founded by Dr. Tim Hart on February 28, 2008 and is headquartered in Begbroke, the United Kingdom. | Chief Executive Officer | - |
Ausbildung von Emma Sceats
| University of Oxford | Doctorate Degree |
| Massachusetts Institute of Technology | Graduate Degree |
| University of Bristol | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ABCAM PLC | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Isogenica Ltd.
Isogenica Ltd. Miscellaneous Commercial ServicesCommercial Services Isogenica Ltd. provides research and development services in the fields of new peptide, antibody and other polypeptide drug candidates. It offers llamdA System, Xab System and 4D Fab System. The company was founded by Kevin Fitzgerald in 2000 and is headquartered in Little Chesterford, the United Kingdom. | Commercial Services |
CN Bio Innovations Ltd.
CN Bio Innovations Ltd. BiotechnologyHealth Technology CN Bio Innovations Ltd. develops and supplies bioengineered solutions. Its products include liver chip system, tissue flex system, contract research services, drug safety profiling, drug metabolism, bespoke tissue models & applications development and technical support. The company was founded by Dr. Tim Hart on February 28, 2008 and is headquartered in Begbroke, the United Kingdom. | Health Technology |
Calico Biolabs, Inc.
Calico Biolabs, Inc. Medical/Nursing ServicesHealth Services Part of Abcam Plc, Calico Biolabs, Inc. is a private company that develops custom rabbit monoclonal antibodies for research and diagnostic use. The company is based in Pleasanton, CA. The company was founded in 2011 by Robert Pytela. The CEO is Emma Sceats. Calico Biolabs was acquired by Abcam Plc on January 28, 2019. | Health Services |
